News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Debt-Ridden Valeant (VRX) Exploring Sale of Its Eye Surgery Equipment Biz, Deal Could Bring in $2.5 Billion



11/3/2016 5:56:36 AM

  Life Sciences Jobs  
  • Newest Jobs - Last 24 Hours
  • California Jobs
  • Massachusetts Jobs
  • New Jersey Jobs
  • Maryland Jobs
  • Washington Jobs
  View More Jobs
Valeant Pharmaceuticals International Inc (VRX.TO) is exploring a sale of its eye-surgery equipment business, which could fetch as much as $2.5 billion, the Wall Street Journal reported.

The sale process is in an early stage and Valeant may still decide not to sell the business, the Journal reported, citing people familiar with the matter. (on.wsj.com/2fwjux5)

The indebted drugmaker said on Wednesday it is in talks with third parties to sell its Salix stomach-drug business and other assets, which could raise as much as $10 billion.

Read at Reuters
Read at Wall Street Journal


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES